T. Rowe Price Associates
HLF icon

T. Rowe Price Associates’s Herbalife HLF Stock Holding History

T. Rowe Price Associates’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,600
Closed -$1.39M – 2523
2015
Q2 		$1.39M Hold
50,600
– – ﹤0.01% 1662
2015
Q1 		$1.08M Buy
+50,600
New +$864K ﹤0.01% 1710

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates's HLF Position: Q2 2026 in Review

T. Rowe Price Associates increased its Herbalife (HLF) stake by 18% in Q2 2026, buying an estimated $273K and bringing the position to 131,637 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2074.

T. Rowe Price Associates first reported a position in HLF in Q2 2013 and has held it in 53 quarters since. The position peaked at $11M in Q4 2013. 235 funds tracked by Wall St. Rank hold HLF as of Q2 2026.

  • T. Rowe Price Associates held 131,637 shares of Herbalife worth $1.73M as of Q2 2026.
  • T. Rowe Price Associates bought 19,833 Herbalife shares in Q2 2026, an estimated $273K.
  • Herbalife made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2074 holding.
  • T. Rowe Price Associates first reported a position in Herbalife in Q2 2013 and has held it in 53 quarters since.
  • T. Rowe Price Associates's Herbalife position peaked at $11M in Q4 2013.
  • 235 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.